Literature DB >> 11738495

Infusion of nerve growth factor (NGF) into kitten visual cortex increases immunoreactivity for NGF, NGF receptors, and choline acetyltransferase in basal forebrain without affecting ocular dominance plasticity or column development.

M A Silver1, M Fagiolini, D C Gillespie, C L Howe, M G Frank, N P Issa, A Antonini, M P Stryker.   

Abstract

Intracerebroventricular or intracortical administration of nerve growth factor (NGF) has been shown to block or attenuate visual cortical plasticity in the rat. In cats and ferrets, the effects of exogenous NGF on development and plasticity of visual cortex have been reported to be small or nonexistent. To determine whether locally delivered NGF affects ocular dominance column formation or the plasticity produced by monocular deprivation in cats at the height of the critical period, we infused recombinant human NGF into the primary visual cortex of kittens using an implanted cannula minipump. NGF had no effect on the normal developmental segregation of geniculocortical afferents into ocular dominance columns as determined both physiologically and anatomically. The plasticity of binocular visual cortical responses induced by monocular deprivation was also normal in regions of immunohistochemically detectable NGF infusion, as measured using intrinsic signal optical imaging and single-unit electrophysiology. Immunohistochemical analysis of the basal forebrain regions of the same animals demonstrated that the NGF infused into cortex was biologically active, producing an increase in the number of NGF-, TrkA-, p75(NTR)-, and choline acetyltransferase-positive neurons in basal forebrain nuclei in the hemisphere ipsilateral to the NGF minipump compared to the contralateral basal forebrain neurons. We conclude that NGF delivered locally to axon terminals of cholinergic basal forebrain neurons resulted in increases in protein expression at the cell body through retrograde signaling.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11738495      PMCID: PMC2452995          DOI: 10.1016/s0306-4522(01)00391-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  84 in total

1.  Reduction in p140-TrkA receptor protein within the nucleus basalis and cortex in Alzheimer's disease.

Authors:  E J Mufson; N Lavine; S Jaffar; J H Kordower; R Quirion; H U Saragovi
Journal:  Exp Neurol       Date:  1997-07       Impact factor: 5.330

2.  Ocular dominance columns and their development in layer IV of the cat's visual cortex: a quantitative study.

Authors:  S LeVay; M P Stryker; C J Shatz
Journal:  J Comp Neurol       Date:  1978-05-01       Impact factor: 3.215

3.  Decreased trkA gene expression within basal forebrain neurons in Alzheimer's disease.

Authors:  E J Mufson; J M Li; T Sobreviela; J H Kordower
Journal:  Neuroreport       Date:  1996-12-20       Impact factor: 1.837

4.  Relationship between the ocular dominance and orientation maps in visual cortex of monocularly deprived cats.

Authors:  M C Crair; E S Ruthazer; D C Gillespie; M P Stryker
Journal:  Neuron       Date:  1997-08       Impact factor: 17.173

5.  Sympathetic axons invade the brains of mice overexpressing nerve growth factor.

Authors:  M D Kawaja; K A Crutcher
Journal:  J Comp Neurol       Date:  1997-06-23       Impact factor: 3.215

6.  Differential modulation of the cholinergic phenotype of the nucleus basalis magnocellularis neurons by applying NGF at the cell body or cortical terminal fields.

Authors:  L Hu; S L Côté; A C Cuello
Journal:  Exp Neurol       Date:  1997-01       Impact factor: 5.330

7.  Nerve growth factor preserves behavioral visual acuity in monocularly deprived kittens.

Authors:  A Fiorentini; N Berardi; L Maffei
Journal:  Vis Neurosci       Date:  1995 Jan-Feb       Impact factor: 3.241

8.  TrkA-immunoreactive profiles in the central nervous system: colocalization with neurons containing p75 nerve growth factor receptor, choline acetyltransferase, and serotonin.

Authors:  T Sobreviela; D O Clary; L F Reichardt; M M Brandabur; J H Kordower; E J Mufson
Journal:  J Comp Neurol       Date:  1994-12-22       Impact factor: 3.215

9.  Inhibition of ocular dominance column formation by infusion of NT-4/5 or BDNF.

Authors:  R J Cabelli; A Hohn; C J Shatz
Journal:  Science       Date:  1995-03-17       Impact factor: 47.728

10.  TrkA expression in the CNS: evidence for the existence of several novel NGF-responsive CNS neurons.

Authors:  D M Holtzman; J Kilbridge; Y Li; E T Cunningham; N J Lenn; D O Clary; L F Reichardt; W C Mobley
Journal:  J Neurosci       Date:  1995-02       Impact factor: 6.167

View more
  5 in total

1.  Intranasal administration of nerve growth factor produces antidepressant-like effects in animals.

Authors:  Cui-ge Shi; Lu-ming Wang; Ying Wu; Peng Wang; Zhu-jun Gan; Kai Lin; Li-xin Jiang; Zhi-qing Xu; Ming Fan
Journal:  Neurochem Res       Date:  2010-06-03       Impact factor: 3.996

Review 2.  What has intrinsic signal optical imaging taught us about NGF-induced rapid plasticity in adult cortex and its relationship to the cholinergic system?

Authors:  Neal Prakash; Ron D Frostig
Journal:  Mol Imaging Biol       Date:  2005 Jan-Feb       Impact factor: 3.488

3.  Knockout of p75NTR does not alter the viability of striatal neurons following a metabolic or excitotoxic injury.

Authors:  Rose Hanbury; Er-Yun Chen; Joanne Wuu; Jeffrey H Kordower
Journal:  J Mol Neurosci       Date:  2003-04       Impact factor: 3.444

4.  Cholinergic abnormalities, endosomal alterations and up-regulation of nerve growth factor signaling in Niemann-Pick type C disease.

Authors:  Carolina Cabeza; Alicia Figueroa; Oscar M Lazo; Carolina Galleguillos; Claudia Pissani; Andrés Klein; Christian Gonzalez-Billault; Nibaldo C Inestrosa; Alejandra R Alvarez; Silvana Zanlungo; Francisca C Bronfman
Journal:  Mol Neurodegener       Date:  2012-03-29       Impact factor: 14.195

5.  Nucleus Basalis of Meynert Stimulation for Dementia: Theoretical and Technical Considerations.

Authors:  Deepak Kumbhare; Viktoras Palys; Jamie Toms; Chathurika S Wickramasinghe; Kasun Amarasinghe; Milos Manic; Evan Hughes; Kathryn L Holloway
Journal:  Front Neurosci       Date:  2018-09-03       Impact factor: 4.677

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.